Related Experiment Video
Updated: May 26, 2026

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
Recent advances in the application of antibodies as therapeutics
Roberta E Burden1, Jill Caswell, Francois Fay
1Molecular Therapeutics, School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK.
Abstract:
The application of antibodies as therapeutic agents in the treatment of cancer now represents a significant proportion of the oncology drug arena. Despite this success, the ability to engineer and exploit antibodies in many different formats is ensuring that new avenues for their therapeutic application are constantly being examined. This review examines a selection of novel antibody-based therapeutic strategies that are currently in late preclinical and clinical evaluation.
Insights
Antibodies are key cancer treatments. Researchers are exploring new antibody formats and strategies for improved cancer therapy, with many novel approaches in late-stage testing.
Area of Science:
- Oncology
- Immunotherapy
- Drug Development
Background:
- Antibodies are a major class of therapeutic agents in cancer treatment.
- Continued engineering of antibody formats expands their therapeutic potential.
Purpose of the Study:
- To review novel antibody-based therapeutic strategies.
- To highlight agents in late preclinical and clinical evaluation.
Main Methods:
- Literature review of recent advancements in antibody therapeutics.
- Focus on strategies in late-stage development.
Main Results:
- Identification of diverse novel antibody formats and applications.
- Overview of promising candidates in preclinical and clinical trials.
Conclusions:
- Novel antibody strategies offer expanding therapeutic avenues in oncology.
- Ongoing research and development are crucial for advancing antibody-based cancer treatments.
More Related Videos
Related Concept Videos
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Cross-reactivity
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Microorganisms in Medicine and Therapeutics
Humoral Immune Responses

